Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Machine Learning algorithms for predicting arrhythmic events in Hypertrophic Cardiomyopathy: limited enhancement beyond late gadolinium enhancement
Session:
SESSÃO DE COMUNICAÇÕES ORAIS 20 - PRÉMIO MELHOR COMUNICAÇÃO ORAL
Speaker:
Joana Certo Pereira
Congress:
CPC 2025
Topic:
B. Imaging
Theme:
03. Imaging
Subtheme:
03.3 Cardiac Magnetic Resonance
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Joana Certo Pereira; Rita Amador; Armando Vieira; Rita Carvalho; Bruno Castilho; Edmundo Arteaga; Carlos Rochitte; João Abecasis; Pedro Lopes; Pedro Freitas; Pedro Adragão; António M. Ferreira
Abstract
<p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Introduction and objectives:</strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">The optimal tool for predicting arrhythmic risk in Hypertrophic cardiomyopathy (HCM) remains a topic of ongoing debate. Artificial intelligence techniques, particularly machine learning (ML) predictive modelling, hold promise for improving risk stratification. The purpose of this study was to develop and assess the performance of a ML model integrating common clinical features to predict arrhythmic events in patients with HCM. </span></span></p> <p> </p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Methods: </strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">We conducted a post-hoc analysis of an international multicenter registry of 530 HCM patients (median age of 49 years (IQR 35-61), 57% male) who underwent cardiac magnetic resonance (CMR) for diagnostic confirmation and risk stratification. The dataset comprised clinical, echocardiographic, and CMR variables, including quantification of late gadolinium enhancement (LGE) using the 6 SD method. The study endpoint was a composite of sudden cardiac death (SCD), aborted SCD, and sustained ventricular tachycardia (VT). A total of 28 events (15 SCDs, 6 aborted SCD and 7 sustained VTs) were accrued over a median follow-up of 4.1 (IQR 1.8-7.3) years. </span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">Using these data, several ML models [including Logistic Regression, Decision Trees, Gradient Boosting Machines, Support Vector Machines and Random Forest (RF)] were developed to predict the study endpoint. The predictive performance of the best model was then compared to the ESC HCM risk score and to the amount of LGE.</span></span></p> <p> </p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Results: </strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">After testing several models, the RF was the most effective method. Key predictive features included LGE percentage, left ventricular ejection fraction, left atrial diameter, and left ventricular indexed mass – Figure 1A. After 5-fold cross-validation, the RF model showed good performance for predicting arrhythmic events, achieving a time-weighted AUC of 0.78 (95% CI: 0.76–0.82, p<0.001). </span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">This performance substantially outperformed the ESC HCM risk score, which achieved a time-weighted AUC of 0.64 (95% CI 0.62-0.67; p < 0.001), p<0.001 for comparison. However, when compared to LGE alone, which attained a time-weighted AUC of 0.76 (95% CI: 0.73–0.84, p<0.001), the RF model provided only a modest, statistically non-significant improvement in predicting the study endpoint (p = 0.817 for comparison).</span></span></p> <p> </p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Conclusion: </strong></span></span></p> <p><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">A machine learning model using readily available clinical variables significantly outperformed the ESC HCM risk score in predicting arrhythmic events in HCM. However, its incremental value over LGE alone was modest, underscoring the strong predictive value of this imaging biomarker. Future research exploring AI-driven image analysis and other innovative approaches may yield better results. </span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site